bestinclass

Stock Market

Sorrento Has Potential To Deliver Multiple Best-In-Class Products

[ad_1] Cantor Fitzgerald initiated coverage on Sorrento Therapeutics Inc (NASDAQ: SRNE) with an Overweight rating and a price target of $5. The analyst…

Read More »
Back to top button
Close